These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 15044102)
21. Melatonin uptake in prostate cancer cells: intracellular transport versus simple passive diffusion. Hevia D; Sainz RM; Blanco D; Quirós I; Tan DX; Rodríguez C; Mayo JC J Pineal Res; 2008 Oct; 45(3):247-57. PubMed ID: 18341516 [TBL] [Abstract][Full Text] [Related]
22. Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design. Di L; Keefer C; Scott DO; Strelevitz TJ; Chang G; Bi YA; Lai Y; Duckworth J; Fenner K; Troutman MD; Obach RS Eur J Med Chem; 2012 Nov; 57():441-8. PubMed ID: 22840492 [TBL] [Abstract][Full Text] [Related]
23. Organic anion transport in HepG2 cells: absence of the high-affinity, chloride-dependent transporter. Min AD; Goeser T; Liu R; Campbell CG; Novikoff PM; Wolkoff AW Hepatology; 1991 Dec; 14(6):1217-23. PubMed ID: 1660021 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and biodistribution of an 18F-labelled resveratrol derivative for small animal positron emission tomography. Gester S; Wuest F; Pawelke B; Bergmann R; Pietzsch J Amino Acids; 2005 Dec; 29(4):415-28. PubMed ID: 15997411 [TBL] [Abstract][Full Text] [Related]
25. Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake. Baker M; Parton T Xenobiotica; 2007; 37(10-11):1110-34. PubMed ID: 17968739 [TBL] [Abstract][Full Text] [Related]
26. Carrier-mediated active transport of histamine H2 receptor antagonists, cimetidine and nizatidine, into isolated rat hepatocytes: contribution of type I system. Nakamura H; Sano H; Yamazaki M; Sugiyama Y J Pharmacol Exp Ther; 1994 Jun; 269(3):1220-7. PubMed ID: 7912279 [TBL] [Abstract][Full Text] [Related]
27. Uptake of biotin by human hepatoma cell line, Hep G2: a carrier-mediated process similar to that of normal liver. Said HM; Ma TY; Kamanna VS J Cell Physiol; 1994 Dec; 161(3):483-9. PubMed ID: 7525615 [TBL] [Abstract][Full Text] [Related]
28. Carrier-mediated hepatic uptake of quinolone antibiotics in the rat. Sasabe H; Terasaki T; Tsuji A; Sugiyama Y J Pharmacol Exp Ther; 1997 Jul; 282(1):162-71. PubMed ID: 9223551 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters. Kusuhara H; Sugiyama Y Drug Metab Rev; 2010 Aug; 42(3):539-50. PubMed ID: 20175646 [TBL] [Abstract][Full Text] [Related]
30. Utility of drug depletion-time profiles in isolated hepatocytes for accessing hepatic uptake clearance: identifying rate-limiting steps and role of passive processes. Jigorel E; Houston JB Drug Metab Dispos; 2012 Aug; 40(8):1596-602. PubMed ID: 22593038 [TBL] [Abstract][Full Text] [Related]
31. Kinetic characterization of rat hepatic uptake of 16 actively transported drugs. Yabe Y; Galetin A; Houston JB Drug Metab Dispos; 2011 Oct; 39(10):1808-14. PubMed ID: 21730030 [TBL] [Abstract][Full Text] [Related]
32. Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells. Shu XH; Li H; Sun Z; Wu ML; Ma JX; Wang JM; Wang Q; Sun Y; Fu YS; Chen XY; Kong QY; Liu J Biochem Pharmacol; 2010 May; 79(10):1516-25. PubMed ID: 20105429 [TBL] [Abstract][Full Text] [Related]
33. Kinetics of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after red wine oral administration in rats. Bertelli AA; Giovannini L; Stradi R; Urien S; Tillement JP; Bertelli A Int J Clin Pharmacol Res; 1996; 16(4-5):77-81. PubMed ID: 9172004 [TBL] [Abstract][Full Text] [Related]
34. Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes. Nakai D; Nakagomi R; Furuta Y; Tokui T; Abe T; Ikeda T; Nishimura K J Pharmacol Exp Ther; 2001 Jun; 297(3):861-7. PubMed ID: 11356905 [TBL] [Abstract][Full Text] [Related]
35. Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans. Watanabe T; Kusuhara H; Maeda K; Kanamaru H; Saito Y; Hu Z; Sugiyama Y Drug Metab Dispos; 2010 Feb; 38(2):215-22. PubMed ID: 19875501 [TBL] [Abstract][Full Text] [Related]
36. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance. Sharp SY; Rogers PM; Kelland LR Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070 [TBL] [Abstract][Full Text] [Related]
37. Bioavailability of resveratrol. Walle T Ann N Y Acad Sci; 2011 Jan; 1215():9-15. PubMed ID: 21261636 [TBL] [Abstract][Full Text] [Related]
38. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist. Imawaka H; Sugiyama Y J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854 [TBL] [Abstract][Full Text] [Related]
39. Stability of trans-resveratrol associated with transport proteins. Pantusa M; Bartucci R; Rizzuti B J Agric Food Chem; 2014 May; 62(19):4384-91. PubMed ID: 24773207 [TBL] [Abstract][Full Text] [Related]
40. Characterization of a human plasma membrane heme transporter in intestinal and hepatocyte cell lines. Worthington MT; Cohn SM; Miller SK; Luo RQ; Berg CL Am J Physiol Gastrointest Liver Physiol; 2001 Jun; 280(6):G1172-7. PubMed ID: 11352810 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]